Zhaohan Wei
Impact in
- Aging top 10%
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Immunology 11
- Phagocytosis and Immune Regulation 6
- Immune cells in cancer 6
- Immunotherapy and Immune Responses 4
-
- Nanoplatforms for cancer theranostics 10
- Co-authors
- Lu Gan (23 shared papers)Xiangliang Yang (23 shared papers)Tuying Yong (19 shared papers)Nana Bie (13 shared papers)Xiaoqiong Zhang (14 shared papers)Guiting Zhan (5 shared papers)Jianye Li (8 shared papers)Bixiang Zhang (3 shared papers)
- Journals
- Nature Communications (3 papers)Nature Biomedical Engineering (2 papers)Journal of Controlled Release (2 papers)Chemical Engineering Journal (2 papers)Nano Today (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Zhaohan Wei
22 papers receiving 1.3k citations
Zhaohan Wei's Hit Papers
Peers
Comparison fields: 5 of 92
- Aging 38
- Biomaterials 283
- Immunology 426
- Biomedical Engineering 706
- Cancer Research 150
Countries citing papers authored by Zhaohan Wei
This map shows the geographic impact of Zhaohan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaohan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaohan Wei more than expected).
Fields of papers citing papers by Zhaohan Wei
This network shows the impact of papers produced by Zhaohan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaohan Wei. The network helps show where Zhaohan Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhaohan Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles Hit paper breakdown → | 2021 | 271 |
| 2 | Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts Hit paper breakdown → | 2022 | 200 |
| 3 | 2019 | 189 | |
| 4 | 2021 | 104 | |
| 5 | 2022 | 92 | |
| 6 | 2023 | 70 | |
| 7 | 2016 | 61 | |
| 8 | 2022 | 54 | |
| 9 | 2022 | 47 | |
| 10 | 2023 | 37 | |
| 11 | 2023 | 31 | |
| 12 | 2021 | 31 | |
| 13 | 2024 | 26 | |
| 14 | 2020 | 26 | |
| 15 | 2022 | 16 | |
| 16 | 2023 | 10 | |
| 17 | 2022 | 5 | |
| 18 | 2025 | 4 | |
| 19 | 2021 | 2 | |
| 20 | 2024 | 2 |
About Zhaohan Wei
Zhaohan Wei is a scholar working on Immunology, Biomedical Engineering, Molecular Biology, Biomaterials and Oncology, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (10 papers), Phagocytosis and Immune Regulation (6 papers), Extracellular vesicles in disease (6 papers), Immune cells in cancer (6 papers), Nanoparticle-Based Drug Delivery (4 papers), Immunotherapy and Immune Responses (4 papers), RNA Interference and Gene Delivery (3 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Aging (38 citations), Biomaterials (283 citations), Immunology (426 citations), Biomedical Engineering (706 citations) and Cancer Research (150 citations). Zhaohan Wei has collaborated with scholars based in China and United States. Frequent co-authors include Lu Gan, Xiangliang Yang, Tuying Yong, Nana Bie, Xiaoqiong Zhang, Guiting Zhan, Jianye Li, Bixiang Zhang, Qingle Liang and Jingjing Yu. Their work appears in journals such as Nature Communications, Nature Biomedical Engineering, Journal of Controlled Release, Chemical Engineering Journal and Nano Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.